The Andhra Pradesh government
on Wednesday placed orders for purchasing 15,000 vials of Liposomal Amphotericin-B injection to treat persons infected with Mucormycosis, also known as Black Fungus, that has been classified as an epidemic disease.
The Centre allotted only 1,650 vials of the injection but since it would not be sufficient, the state has decided to purchase a large quantity on its own as cases of Black Fungus were being reported, Principal Secretary (Health) Anil Kumar Singhal said.
Each infected patient would require 60 vials of the injection and each would cost about Rs 5,000-6,000.
"The treatment is very costly and hence we have brought it under the Aarogya Sri Health Insurance scheme so that affected people could avail of free treatment," the official said.
He said detailed reports were being obtained from the districts on the exact number of Black Fungus cases reported in the state.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)